Global X Robo Global Robotics & Automation ETF vs Revolution Medicines Inc. Common Stock — how do they compare? Global X Robo Global Robotics & Automation ETF trades at $81.23 (market cap $2.06B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 19.6× Global X Robo Global Robotics & Automation ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Global X Robo Global Robotics & Automation ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X Robo Global Robotics & Automation ETF for 36 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| ROBO | RVMD | |
|---|---|---|
Market Cap | $2.06B | $40.32B |
Volume | 148,111 | 4,855,734 |
Sector | Sector/Thematic | Health |
52-Week High | $90.34 | $221.15 |
52-Week Low | $63.04 | $47.50 |
Typical Hold Time | 36 Days | 0 Days |
Enterprise Value | — | $37.02B |
Signals from Pluang's Aura AI — not financial advice
ROBO trades at $81.26, down 0.68% on the day, with a bullish technical signal from moving averages but bearish oscillators. The stock shows strong institutional interest in robotics and AI themes, with recent news highlighting accelerating adoption across manufacturing, healthcare, and military applications. Financial ratios are unavailable in the current dataset.
The robotics sector offers long-term growth potential amid labor shortages and AI integration, though high RSI levels suggest near-term overbought conditions. Key risks include valuation concerns and sector competition, while analyst coverage remains favorable for diversified robotics exposure.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.
Read more on ROBO →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →